Novo Nordisk's bispecific antibody FREHEMGO wins EMA committee backing for haemophilia A. Monthly, fortnightly or weekly dosing in a pre-filled pen. EU approval expected.
Novo Nordisk wins CHMP nod for denecimig in haemophilia A
The EMA advisory committee recommended EU approval of FREHEMGO, a bispecific antibody offering monthly, fortnightly or weekly dosing in a pre-filled pen.
biotech.disruptsmedia.com
September 21, 2026 at 2:45 PM
Novo Nordisk's bispecific antibody FREHEMGO wins EMA committee backing for haemophilia A. Monthly, fortnightly or weekly dosing in a pre-filled pen. EU approval expected.
#Novo #obesity #patentprotection #Wegovy #weightloss #Ozempic #diabetes #CagriSema #Foundayo #Haematology #haemophiliaA #Frehemgo #sicklecelldisease #PNH #blooddisorders #endocrinedisorders #liverdiseases #cardiovasculardisease #consumerRx #pain #addiction #menshealth #womenshealth
zurl.co/Lmdba
zurl.co/Lmdba
Under pressure, Novo lays out blockbuster launch plans
Novo has revealed a plan to launch five or more blockbusters between now and 2030 that it hopes will grow annual revenues by around $23bn.
zurl.co
September 24, 2026 at 8:52 AM
#Novo has moved a step closer to #EU approval of its long-acting #haemophiliaA therapy, #Frehemgo, after it was backed by the #EMA's human medicines committee.
pharmaphorum.com/news/chmp-ba...
pharmaphorum.com/news/chmp-ba...
CHMP backs Novo's haemophilia A drug Frehemgo
Novo has moved a step closer to EU approval of its long-acting haemophilia A therapy, Frehemgo, which could be a future blockbuster.
pharmaphorum.com
September 18, 2026 at 12:10 PM
#Novo has moved a step closer to #EU approval of its long-acting #haemophiliaA therapy, #Frehemgo, after it was backed by the #EMA's human medicines committee.
pharmaphorum.com/news/chmp-ba...
pharmaphorum.com/news/chmp-ba...
CHMP backs FREHEMGO for haemophilia A in children and adults. #$NVO also partners with Orbis on oral cardiometabolic medicines worth up to $1.4B. notreload.xyz/xy/novo-eu-n...
Novo: EU nod for FREHEMGO + $1.4bn oral-drug deal
CHMP recommends FREHEMGO (denecimig) for haemophilia A, with or without inhibitors. Novo and Orbis will develop oral cardiometabolic drugs.
notreload.xyz
September 17, 2026 at 4:04 PM
CHMP backs FREHEMGO for haemophilia A in children and adults. #$NVO also partners with Orbis on oral cardiometabolic medicines worth up to $1.4B. notreload.xyz/xy/novo-eu-n...
🟢 #$NVO — Regulatory Designation
CHMP Positive Opinion - FREHEMGO (denecimig) Recommended for EU Approval in Haemophilia A
On September 17, 2026, the CHMP of the EMA adopted a positive opinion recommending marketing authorisation for FREHEMGO (denecimig) to trea…
https://biostock.app/symbols/NVO
CHMP Positive Opinion - FREHEMGO (denecimig) Recommended for EU Approval in Haemophilia A
On September 17, 2026, the CHMP of the EMA adopted a positive opinion recommending marketing authorisation for FREHEMGO (denecimig) to trea…
https://biostock.app/symbols/NVO
September 17, 2026 at 5:28 PM
🟢 #$NVO — Regulatory Designation
CHMP Positive Opinion - FREHEMGO (denecimig) Recommended for EU Approval in Haemophilia A
On September 17, 2026, the CHMP of the EMA adopted a positive opinion recommending marketing authorisation for FREHEMGO (denecimig) to trea…
https://biostock.app/symbols/NVO
CHMP Positive Opinion - FREHEMGO (denecimig) Recommended for EU Approval in Haemophilia A
On September 17, 2026, the CHMP of the EMA adopted a positive opinion recommending marketing authorisation for FREHEMGO (denecimig) to trea…
https://biostock.app/symbols/NVO
Novo Nordisk (NVO) Stock: Surges as Haemophilia Drug Nears EU Approval
Novo Nordisk's haemophilia drug FREHEMGO nears EU approval, boosting stock by 2.83%.
https://blockonomi.com/novo-nordisk-nvo-stock-surges-as-haemophilia-drug-nears-eu-approval/
Novo Nordisk's haemophilia drug FREHEMGO nears EU approval, boosting stock by 2.83%.
https://blockonomi.com/novo-nordisk-nvo-stock-surges-as-haemophilia-drug-nears-eu-approval/
September 18, 2026 at 12:01 PM
Novo Nordisk (NVO) Stock: Surges as Haemophilia Drug Nears EU Approval
Novo Nordisk's haemophilia drug FREHEMGO nears EU approval, boosting stock by 2.83%.
https://blockonomi.com/novo-nordisk-nvo-stock-surges-as-haemophilia-drug-nears-eu-approval/
Novo Nordisk's haemophilia drug FREHEMGO nears EU approval, boosting stock by 2.83%.
https://blockonomi.com/novo-nordisk-nvo-stock-surges-as-haemophilia-drug-nears-eu-approval/
Two CHMP opinions today. Neither is an EU MA.
Frehemgo in haemophilia A. Pepaxti toward 3L myeloma.
https://europepharmatoday.com/pulse/2026-09-17?utm_source=bluesky&utm_medium=social&utm_campaign=pulse-2026-09-17
#CHMP
Frehemgo in haemophilia A. Pepaxti toward 3L myeloma.
https://europepharmatoday.com/pulse/2026-09-17?utm_source=bluesky&utm_medium=social&utm_campaign=pulse-2026-09-17
#CHMP
September 17, 2026 at 5:11 PM
Two CHMP opinions today. Neither is an EU MA.
Frehemgo in haemophilia A. Pepaxti toward 3L myeloma.
https://europepharmatoday.com/pulse/2026-09-17?utm_source=bluesky&utm_medium=social&utm_campaign=pulse-2026-09-17
#CHMP
Frehemgo in haemophilia A. Pepaxti toward 3L myeloma.
https://europepharmatoday.com/pulse/2026-09-17?utm_source=bluesky&utm_medium=social&utm_campaign=pulse-2026-09-17
#CHMP
NOVO: CHMP RECOMMENDS EU APPROVAL OF FREHEMGO® (DENECIMIG), THE FIRST FACTOR VIIIA MIMETIC OFFERING MONTHLY, ONCE EVERY TWO WEEKS AND WEEKLY DOSING IN A PRE-FILLED PEN, FOR THE TREATMENT OF HAEMOPHILIA A
September 17, 2026 at 2:18 PM
NOVO: CHMP RECOMMENDS EU APPROVAL OF FREHEMGO® (DENECIMIG), THE FIRST FACTOR VIIIA MIMETIC OFFERING MONTHLY, ONCE EVERY TWO WEEKS AND WEEKLY DOSING IN A PRE-FILLED PEN, FOR THE TREATMENT OF HAEMOPHILIA A
EU regulators recommend approval of Novo Nordisk drug Frehemgo for Haemophilia A. Silver prices rose 5 percent to 66.13 dollars per ounce. President Dan nominated Siegfried Muresan for Romanian Prime Minister. A 6.3 magnitude earthquake struck Nikolski, Alaska.
September 17, 2026 at 2:43 PM
EU regulators recommend approval of Novo Nordisk drug Frehemgo for Haemophilia A. Silver prices rose 5 percent to 66.13 dollars per ounce. President Dan nominated Siegfried Muresan for Romanian Prime Minister. A 6.3 magnitude earthquake struck Nikolski, Alaska.
